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AAA Rupture Often Occurs Outside the Maximal Diameter Region
and is Preceded by Rapid Local Growth and an Increased
Biomechanical Rupture Risk Index
A. Siika, M.L. Liljeqvist, R. Hultgren, C. Gasser, J. Roy
Karolinska Institutet, Stockholm, Sweden
Introduction: Rupture risk prediction of abdominal aortic aneurysms (AAA)
relies on maximal diameter (Dmax) measurements. If Dmax exceeds 55 mm
aortic surgery is considered beneﬁcial. However, even small aneurysms
rupture while some large aneurysms never rupture. Our objective was to
study the size and location of ruptures in AA patients in our center and to
relate the location and growth of the local rupture site to the Dmax.
Furthermore, we studied whether the biomechanical rupture risk esti-
mated using ﬁnite element analysis (FEA) could predict rupture.
Methods: All patients diagnosed with AAA rupture (treated or not
treated) in our catchment area during the years 2009e2013 were included.
50 patients had undergone high quality computed tomography angiog-
raphy examination. Dmax, orthogonally to the centerline, local diameter at
the rupture site and its distance from the Dmax region was recorded. 14
patients had a previous CTA conducted within 2 years prior to AAA rupture.
FEA was performed and Peak wall stress (PWS) and Peak wall rupture index
(PWRI ¼ maximal wall stress/wall strength ratio) were calculated using A4
Clinics software (VASCOPS, Austria).
Results: Themedian diameter at rupture was 77mm.Two rAAAs (4%) had
aDmax<55mmandﬁve (10%)had aDmax<60mm. 50%of the30 identiﬁed
rupture sites were located outside the Dmax region. In the 14 patients with a
pre-rupture CTA, PWRI was signiﬁcantly higher than in the control group
(0.41 vs. 0.34, p ¼ 0.005) but no signiﬁcant differences in PWS (212 vs.
197 kPa, p ¼ 0.20) or maximal diameter (61 vs. 58 mm, p ¼ 0.23) were
detected. Diameter growth rate between the pre-rupture and rupture CTs
was in 67% of the cases higher in the rupture region than in the Dmax region.
Conclusion: In this cohort of all consecutive rAAA patients (treated and
not treated), a signiﬁcant number of ruptured aneurysms had small di-
ameters at rupture. Ruptures often occurred outside the maximal diameter
area, sometimes in segments with a relatively small local diameter. In the
small cohort of rupture patients with a pre-rupture CTA, FEA could predict
AAA rupture. In addition, rupture sites were preceded by rapid local growth.
Our results support the notion of considering the entire geometry of an
aneurysm, rather than sole reliance on maximum diameter measurements.
Comparison of Renal Outcomes in Matched Cohorts Treated by
Zenith Fenestrated and Zenith AAA Stent Grafts in US
Prospective Pivotal Trials
L.R. de Souza, G.S. Oderich, S. Textor, M.A. Farber, S. Haulon,
P. Banga, P. Gloviczki, F. Jia
Vascular and Endovascular Surgery Division, Mayo Clinic, Rochester, MN, USA
Introduction: Fenestrated endovascular repair (FEVAR) has been increasingly
utilized to treat complex abdominal aortic aneurysms (AAAs). The added riskE-mail address: esvs.secretary@btconnect.com (S. Parvin).
1078-5884/$ e see front matterof renal function deterioration as compared to patients undergoing infra-
renal endovascular aortic repair (EVAR) has not yet been determined.
Methods: Patients with preserved renal function (eGFR  45 ml/min)
enrolled in two prospective, non-randomized pivotal studies evaluating the
Zenith fenestrated and Zenith AAA stent grafts (Cook Medical Inc.,
Bloomington IN) were matched (1:2) by propensity scores for age, gender,
hypertension, diabetes, and pre-operative eGFR. There were 67 patients
treated by FEVAR and 134 matched controls treated by EVAR. Mean follow
up was 30  20 months. Renal outcomes included acute kidney injuries
deﬁned by RIFLE criteria (Risk, Injury, Failure, Loss, End-stage) and changes
in sCr, eGFR, and CKD staging up to 5 years. Renal duplex ultrasound follow
up was obtained only in the FEVAR group.
Results: Acute kidney injury at one month were similar between
groups with >50% decline in eGFR observed in 6% of FEVAR and 11% of
EVAR patients (P ¼ 0.68). There were no signiﬁcant differences in >25%
decline in eGFR at 2-years (20% vs. 20%; P ¼ 0.99) and 5 years (27% vs.
50%, P ¼ 0.50) between patients treated by FEVAR or EVAR, respectively.
Progression to stage IV-V CKD was similar at 2-years (2% vs. 3%; P ¼ 0.99)
and 5 years (7% vs. 8%, P ¼ 0.94) in the FEVAR and EVAR groups, with
similar sCr and eGFR values up to 5 years. During follow up, there were
more renal artery stenosis/occlusions (15/67 vs. 3/134, P < 0.001) and
more renal related re-interventions (12/67 vs. 4/134, p < 0.001) in pa-
tients treated by FEVAR compared to EVAR, respectively. However, rate of
progression to renal failure requiring dialysis was low and identical in both
groups (1.4% vs. 1.4%, P ¼ 0.99).
Conclusion: Endovascular aortic repair with fenestrated and infra-renal
AAA stent grafts was associated with similar rates of renal function
deterioration in patients who initially had preserved renal function. Renal-
related re-interventions were higher following FEVAR, although net
changes in renal function were similar in both groups. Surveillance of renal
artery alignment stents is recommended to detect stenosis or occlusion
after FEVAR. In patients with preserved renal function, the decision on
type of repair should be based upon anatomical factors such as length of
infra-renal aortic sealing zone and aneurysm involvement of the visceral
arteries, rather than impact on renal function status.
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Introduction: The Nellix Endovascular Aneurysm Sealing (EVAS) has been
proposed as an alternative to conventional endovascular aneurysm repair
in attempt to deal with the limitations of this method, speciﬁcally, endo-
leaks and migration. The aim of the study was to present our experience in
the treatment of patients with abdominal aortic aneurysms (AAA) with
challenging neck anatomy.
Methods: From January 2014 to April 2015, 50 patients (43 male, 7
female), aged 56e87, underwent implantation of Nellix stent graft for AAA.
In one case an emergency procedure was performed in a patient with
secondary aneurysm rupture due to bifurcated stent graft migration. The
procedures were performed under spinal (41) or general anesthesia (9).
Results: All procedures were completed without complications. In ﬁve
cases the procedure was performed beyond instruction for use. Four renal
